pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 2
roxadustat
roxadustat
Myelodysplastic Syndrome (Preleukemia)
$KYNB
KYNTRA BIO, INC.
Marketed
rufinamide
Banzel (rufinamide)
Lennox-Gastaut Syndrome
Eisai Co Ltd
pre_registration
rusfertide acetate
rusfertide acetate
Polycythemia Vera
$PTGX
Protagonist Therapeutics, Inc
Phase 2
← prev
page 215 of 231
next →
Pain
89
Neurology
1
ruxoprubart
ruxoprubart
Paroxysmal Nocturnal Hemoglobinuria
NovelMed Therapeutics Inc
Phase 2
ruxotemitide
Oncopore (ruxotemitide [INN])
Metastatic Melanoma
Lytix Biopharma ASA
Phase 2
sabirnetug
sabirnetug
Alzheimer's Disease
$ABOS
Acumen Pharmaceuticals, Inc.
Preclinical
sabizabulin hydrochloride
sabizabulin hydrochloride
Ebolavirus Infections (Ebola Hemorrhagic Fever)
$VERU
VERU INC.
Phase 2
sacituzumab drozuntecan
sacituzumab drozuntecan [INN]
Epithelial Ovarian Cancer
$BNTX
BioNTech SE
Phase 3
sacituzumab tirumotecan
sacituzumab tirumotecan
Adenocarcinoma Of The Gastroesophageal Junction
$MRK
Merck & Co., Inc.
Marketed
sacrosidase
Sucraid (sacrosidase)
Congenital Sucrase-Isomaltase Deficiency (CSID)
QOL Medical LLC
Marketed
safinamide mesylate
Safinamide Mesylate
Parkinson's Disease
Zenara Pharma Pvt Ltd
Phase 3
safusidenib
safusidenib [INN]
Malignant Glioma
$NUVB
Nuvation Bio Inc.
Phase 3
salanersen
salanersen
Spinal Muscular Atrophy (SMA)
$BIIB
BIOGEN INC.
Marketed
salmeterol xinafoate
Serevent Diskus (salmeterol xinafoate)
Asthma
GlaxoSmithKline LLC
Preclinical
salsalate
salsalate
Polycystic Kidney Disease
J and D Pharmaceuticals LLC
Phase 2
samelisant
samelisant [INN]
Narcolepsy
Suven Life Sciences Ltd
Phase 2
sapablursen sodium
sapablursen sodium
Polycythemia Vera
Ono Pharmaceutical Co Ltd
Phase 2
saracatinib difumarate
saracatinib difumarate
Idiopathic Pulmonary Fibrosis
$AZN
ASTRAZENECA PLC
Marketed
sarecycline hydrochloride
Seysara (sarecycline hydrochloride)
Acne Vulgaris
Almirall SA
Phase 3
sargramostim
Leukine (sargramostim)
Metastatic Melanoma
Partner Therapeutics Inc
Phase 2
sarilumab
Kevzara (sarilumab)
Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease)
$REGN
REGENERON PHARMACEUTICALS, INC.
Phase 3
saroglitazar magnesium
Lipaglyn (saroglitazar magnesium)
Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Zydus Therapeutics Inc
Phase 3
satralizumab
Enspryng (satralizumab-mwge)
Demyelinating Diseases
F. Hoffmann-La Roche Ltd
Phase 2
satricabtagene autoleucel
satricabtagene autoleucel
Adenocarcinoma Of The Gastroesophageal Junction
CARsgen Therapeutics Holdings Ltd
Phase 2
savolitinib
savolitinib
Non-Small Cell Lung Cancer
$AZN
ASTRAZENECA PLC
Marketed
saxagliptin
Saxagliptin
Type 2 Diabetes
Glenmark Pharmaceuticals Ltd
Marketed
scorpion [centruroides] (polyvalent) immunoglobulin F(ab’) 2 antivenom [equine]
Anascorp
Poisoning
Rare Disease Therapeutics Inc
Marketed
sebelipase alfa
Kanuma (sebelipase alfa)
Lysosomal Acid Lipase Deficiency
Alexion Pharmaceuticals Inc
Marketed
sebetralstat
Ekterly (sebetralstat [INN])
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…
$KALV
KalVista Pharmaceuticals, Inc.
Marketed
secnidazole
Solosec (secnidazole)
Bacterial Vaginosis
$EVFM
Evofem Biosciences, Inc.
